Acura Pharmaceuticals (ACUR +47.9%) shares skyrocket ~50%, apparently due to a report from...


Acura Pharmaceuticals (ACUR +47.9%) shares skyrocket ~50%, apparently due to a report from EMPR.com that its Nexafed drug will be available soon. Nexafed is an immediate-release next generation pseudoephedrine tablet which combines nasal congestion relief with ACUR's IMPEDE technology that disrupts the conversion of pseudoephedrine into methamphetamine.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs